Unbiased AI-powered news
1 stories related to this topic, newest first.
manilatimes.netA Nature Medicine analysis of the DECLARE-TIMI 58 trial found dapagliflozin produced an eightfold greater reduction in heart failure hospitalization among carriers of cardiomyopathy-linked genetic variants than among non-carriers.